Skip to main content
. Author manuscript; available in PMC: 2022 Jan 3.
Published in final edited form as: Exp Hematol. 2021 May 21;99:1–11. doi: 10.1016/j.exphem.2021.05.004

Figure 1.

Figure 1

Upregulation of SOCS2 is associated with relapse and poor outcome of AML, and SOCS2 promotes AML progression and stem cell-related properties. act=activity; Dx=diagnosis; Rel=relapse.